source
- Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M dealDimerix has bought an acute kidney injury drug from Mission Therapeutics, paying $5 million upfront and committing up to $287 million in milestones for the phase 2-ready asset.Fierce Biotech · 14d ago↗ source
- Biotronik Neuro snaps up spinal cord stimulation portfolio from Soin Neuroscience for next-gen pain projectBiotronik Neuro has acquired a portfolio of spinal cord stimulation patents from the Ohio-based medical device company Soin Neuroscience as the pair look to create “a next-generation spinal cord st…Fierce Biotech · 14d ago↗ source
- Khong Guan Corporation Issues Recall of Glutinous Rice Balls With Black Sesame Filling Due to Undeclared PeanutsKhong Guan Corporation is recalling specific lots of “Glutinous Rice Balls with Black Sesame Filling” because they may contain undeclared peanuts. People who have an allergy or severe sensitivity t…